Vila V - Search Results

1

Hypercoagulable state after thrombolytic therapy in patients with acute myocardial infarction (AMI) treated with streptokinase.

Vila V, Regañón E, Aznar J, Lacueva V, Ruano M, Laiz B. Vila V, et al. Thromb Res. 1990 Mar 1;57(5):783-94. doi: 10.1016/0049-3848(90)90035-b. Thromb Res. 1990. PMID: 2339369

2

Inflammation, fibrinogen and thrombin generation in patients with previous myocardial infarction.

Réganon E, Vila V, Martínez-Sales V, Vaya A, Aznar J. Réganon E, et al. Among authors: vila v. Haematologica. 2002 Jul;87(7):740-5; discussion 745. Haematologica. 2002. PMID: 12091125

3

Influence of plasma and erythrocyte factors on red blood cell aggregation in survivors of acute myocardial infarction.

Vayá A, Falcó C, Réganon E, Vila V, Martínez-Sales V, Corella D, Contreras MT, Aznar J. Vayá A, et al. Among authors: vila v. Thromb Haemost. 2004 Feb;91(2):354-9. doi: 10.1160/TH03-08-0497. Thromb Haemost. 2004. PMID: 14961164

4

Association between inflammation and hemostatic markers in atherothrombotic stroke.

Reganon E, Vila V, Martínez-Sales V, Vaya A, Lago A, Alonso P, Aznar J. Reganon E, et al. Among authors: vila v. Thromb Res. 2003;112(4):217-21. doi: 10.1016/j.thromres.2003.12.008. Thromb Res. 2003. PMID: 14987914

5

Sialic acid is an inflammation marker associated with a history of deep vein thrombosis.

Reganon E, Vila V, Martínez-Sales V, Vayá A, Mira Y, Ferrando F, Aznar J. Reganon E, et al. Among authors: vila v. Thromb Res. 2007;119(1):73-8. doi: 10.1016/j.thromres.2005.12.017. Epub 2006 Feb 28. Thromb Res. 2007. PMID: 16500696

6

Human fibrinogen heterogeneity. A study of limited fibrinogen degradation.

Regañón E, Vila V, Aznar J, Laiz B. Regañón E, et al. Among authors: vila v. Clin Chim Acta. 1989 Sep 15;184(1):7-17. doi: 10.1016/0009-8981(89)90252-0. Clin Chim Acta. 1989. PMID: 2532081

7

Study of the formation of fibrin clot in cirrhotic patients. An approach to study of acquired dysfibrinogenemia.

Regañón E, Vila V, Aznar J, Garrido G, Estellés A, Berenguer J. Regañón E, et al. Among authors: vila v. Thromb Res. 1987 Jun 1;46(5):705-14. doi: 10.1016/0049-3848(87)90272-6. Thromb Res. 1987. PMID: 3629544

8

Studies on the functionality of newly synthesized fibrinogen after treatment of acute myocardial infarction with streptokinase, increase in the rate of fibrinopeptide release.

Reganon E, Vila V, Aznar J, Lacueva V, Martinez V, Ruano M. Reganon E, et al. Among authors: vila v. Thromb Haemost. 1993 Dec 20;70(6):978-83. Thromb Haemost. 1993. PMID: 8165621 Clinical Trial.

9

Fibrinopeptide A release from intraplatelet fibrinogen is related to thrombin platelet activation.

Vila V, Martinez-Sales V, Réganon E, Aznar J. Vila V, et al. Thromb Res. 1997 May 1;86(3):263-9. doi: 10.1016/s0049-3848(97)00069-8. Thromb Res. 1997. PMID: 9175247 No abstract available.

10

Increase in thrombin generation after coronary thrombolysis with rt-PA or streptokinase with simultaneous heparin versus heparin alone.

Réganon E, Ferrando F, Vila V, Villa P, Martínez-Sales V, Fayos L, Ruano M, Aznar J. Réganon E, et al. Among authors: vila v. Haemostasis. 1998 Mar-Apr;28(2):99-105. doi: 10.1159/000022419. Haemostasis. 1998. PMID: 10087435 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters